Pfizer announced that Dr. Mikael Dolsten, chief scientific officer and president of Pfizer research and development (R&D), will be leaving the company. In a press release Tuesday morning, the pharma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results